Form D · Biotechnology

FibroGen China Anemia Holdings, Ltd.

Grand Cayman, E9 · CIK 0001555069

Offering snapshot reported Jan 14, 2013 · SEC filing

Reported sold
$6.71M
Indefinite offering
Investors reported
53
Form D · investor count
Minimum accepted
$2.2K
Reported outside-investor minimum
First sale
Jul 11, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3.35M$6.71MJul 27, 2012: $6,023,000.00Jul 27, 2012Jan 14, 2013: $6,708,000.00Jan 14, 2013

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$6,023,000 → $6,708,000
  • Reported investors43 → 53

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 14, 2013Amendment$6,708,000$685,000vs Jul 27, 201253SEC filing
Jul 27, 2012Initial$6,023,000No comparison43SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-181913

Source: Form D, filed Jan 14, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thomas B Neff Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
C/O Ogier Fiduciary Services (Cayman)Ltd 89 Nexus Way
Grand Cayman, E9, KY1-9007